OrbiMed Advisors LLC's Form 4 filing
NeuroPace Inc (NPCE) · filed May 16, 2025
- Accession no.
- 0000947871-25-000548
- Filed
- May 16, 2025, 5:26 PM ET
- Trade date
- May 14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.67M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Common Stock | SSaleDisposed | −134,136 | $15.83 | −$2,123,372.88 | 3,272,199 | Indirect | |
| May 14, 2025 | Common Stock | SSaleDisposed | −34,000 | $15.94 | −$541,960 | 3,238,199 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.